Related Experiment Video
Updated: Jun 23, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells
Hana Radilova1, Antonin Libra, Sarka Holasova
1GENERI BIOTECH s.r.o, Hradec Kralove, Czech Republic. hana.radilova@generi-biotech.com
Abstract:
Cyclooxygenases are key enzymes in the arachidonic acid metabolism. Their unstable intermediate, prostaglandin H(2), is further metabolized to bioactive lipids by various downstream enzymes. In this study, utilizing short hairpin RNAs, we prepared a cell line of human cervix carcinoma with stable down-regulated cyclooxygenase-1 (COX-1) to assess the impact of COX-1 reduction on the downstream enzymes. We found a significant microsomal prostaglandin E synthase-1 (mPGES-1) suppression. In addition, mRNA expression of multidrug resistance protein 4 (MRP4, ABCC4), supposed to take part in antiviral and anticancer drug transport from cells, was up-regulated after COX-1 down-regulation. Our findings indicate that mPGES-1, believed to be coexpressed preferentially with cyclooxygenase-2, may be coupled to COX-1. ABCC4 up-regulation further supports the assumption of its involvement in prostanoid transport.
Insights
Down-regulating cyclooxygenase-1 (COX-1) in cervix carcinoma cells suppressed microsomal prostaglandin E synthase-1 (mPGES-1). This also increased multidrug resistance protein 4 (MRP4, ABCC4) expression, impacting drug transport and prostanoid metabolism.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Cyclooxygenases (COX) are crucial enzymes in arachidonic acid metabolism, producing prostaglandin H(2).
- Prostaglandin H(2) is a precursor to various bioactive lipids synthesized by downstream enzymes.
- Understanding the regulation of these pathways is vital for cancer research and drug development.
Purpose of the Study:
- To investigate the impact of cyclooxygenase-1 (COX-1) down-regulation on downstream enzymes in human cervix carcinoma cells.
- To explore the relationship between COX-1 and microsomal prostaglandin E synthase-1 (mPGES-1) expression.
- To assess changes in multidrug resistance protein 4 (MRP4, ABCC4) expression following COX-1 reduction.
Main Methods:
- Generation of a human cervix carcinoma cell line with stably down-regulated COX-1 using short hairpin RNAs (shRNAs).
- Analysis of downstream enzyme expression, including mPGES-1 and MRP4 (ABCC4), via molecular techniques.
- Quantitative assessment of mRNA expression levels for key enzymes.
Main Results:
- Significant suppression of microsomal prostaglandin E synthase-1 (mPGES-1) was observed after COX-1 down-regulation.
- mRNA expression of multidrug resistance protein 4 (MRP4, ABCC4) was significantly up-regulated.
- These findings suggest a potential coupling between COX-1 and mPGES-1, contrary to previous assumptions of mPGES-1 co-expression with COX-2.
Conclusions:
- Microsomal prostaglandin E synthase-1 (mPGES-1) may be functionally coupled with cyclooxygenase-1 (COX-1), not exclusively with COX-2.
- Up-regulation of ABCC4 suggests its role in prostanoid transport and potential involvement in drug resistance mechanisms.
- This study provides novel insights into the complex regulatory network of arachidonic acid metabolism in cancer cells.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Cell Specific Gene Expression
G-protein Coupled Receptors
Anaphase Promoting Complex
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...